293 related articles for article (PubMed ID: 25007375)
21. The critical role of the vehicle to therapeutic efficacy and patient compliance.
Piacquadio D; Kligman A
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S67-73. PubMed ID: 9703127
[No Abstract] [Full Text] [Related]
22. Topical treatments.
Pantling L
Nurs Stand; 2013 Nov 20-26; 28(12):61. PubMed ID: 24251517
[No Abstract] [Full Text] [Related]
23. Topical treatments in dermatology still going strong.
van de Kerkhof PC
J Dermatolog Treat; 2010 May; 21(3):125. PubMed ID: 20394487
[No Abstract] [Full Text] [Related]
24. Is all "skin in the game" fair game? The problem with "non-preferred" generics.
Oster G; Fendrick AM
Am J Manag Care; 2014 Sep; 20(9):693-5. PubMed ID: 25365744
[No Abstract] [Full Text] [Related]
25. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2014 Jul; 13(7):s77-83. PubMed ID: 25007376
[TBL] [Abstract][Full Text] [Related]
26. [The dermocorticoids, irreplaceable and feared].
Zenklusen C; Feldmeyer L
Rev Med Suisse; 2014 Apr; 10(425):821-6. PubMed ID: 24791429
[TBL] [Abstract][Full Text] [Related]
27. Key developments in dermatology.
Smith V; Sharpe G
Practitioner; 2005 Jun; 249(1671):398, 400, 402 passim. PubMed ID: 15966274
[No Abstract] [Full Text] [Related]
28. Biosimilars in dermatology: starting with infliximab.
Puig L
Actas Dermosifiliogr; 2013 Apr; 104(3):175-80. PubMed ID: 23218608
[No Abstract] [Full Text] [Related]
29. The roles of the pharmaceutical industry and drug development in dermatology and dermatologic health care.
Altman DJ
Dermatol Clin; 2000 Apr; 18(2):287-96. PubMed ID: 10791155
[TBL] [Abstract][Full Text] [Related]
30. What's new in dermatology? New topical agents.
Stone MS
Iowa Med; 1991 May; 81(5):200-1. PubMed ID: 1869419
[No Abstract] [Full Text] [Related]
31. [Comments on topical dermatologic treatment].
Taube KM; Wozniak KD
Z Arztl Fortbild (Jena); 1989; 83(6):323-5. PubMed ID: 2735078
[No Abstract] [Full Text] [Related]
32. [Biochemistry, pharmacology and toxicology of urea].
Raab W
Hautarzt; 1989; 40 Suppl 9():23-6. PubMed ID: 2681074
[TBL] [Abstract][Full Text] [Related]
33. [Urea in topical therapy of skin diseases--principles and use].
Wohlrab WA
Z Arztl Fortbild (Jena); 1993 Aug; 87(8):643-50. PubMed ID: 8379203
[No Abstract] [Full Text] [Related]
34. Quality and equivalence of topical products: A critical appraisal.
Miranda M; Cardoso C; Vitorino C
Eur J Pharm Sci; 2020 May; 148():105082. PubMed ID: 31626969
[TBL] [Abstract][Full Text] [Related]
35. [Local treatments in dermatology].
Moureaux P
Allerg Immunol (Paris); 1995 Jun; 27(6):200-5. PubMed ID: 7626195
[No Abstract] [Full Text] [Related]
36. An Update of the Brazilian Regulatory Bioequivalence Recommendations for Approval of Generic Topical Dermatological Drug Products.
Soares KC; Santos GM; Gelfuso GM; Gratieri T
AAPS J; 2015 Nov; 17(6):1517-8. PubMed ID: 26122498
[TBL] [Abstract][Full Text] [Related]
37. A brief history of generic substitution in the USA.
Sullivan CG
Pharm Pat Anal; 2012 Mar; 1(1):9-11. PubMed ID: 24236706
[No Abstract] [Full Text] [Related]
38. [Future of topical therapy].
Wohlrab J; Staubach P
Hautarzt; 2014 Mar; 65(3):168. PubMed ID: 24622850
[No Abstract] [Full Text] [Related]
39. Drug treatments for skin disease introduced in 2006.
Skin Therapy Lett; 2007 May; 12(4):4-7. PubMed ID: 17551663
[TBL] [Abstract][Full Text] [Related]
40. [Comments on generic antibiotics].
Levêque D; Gourieux B
Med Mal Infect; 2013 Jan; 43(1):35-6. PubMed ID: 23287656
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
